| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001525 | Angiogenesis | Increases phenotype | PMID:22905168; PMID:25081364 |
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:29969652; PMID:34597818; PMID:35762964 |
| GO:0001547 | Antral ovarian follicle growth | Decreases phenotype | PMID:28013214 |
| GO:0001568 | Blood vessel development | Increases phenotype | PMID:37021957 |
| GO:0001825 | Blastocyst formation | Decreases phenotype | PMID:36756972 |
| GO:0002191 | Cap-dependent translational initiation | Affects phenotype | PMID:27992464 |
| GO:0003006 | Developmental process involved in reproduction | Affects phenotype | PMID:37788136 |
| GO:0003093 | Regulation of glomerular filtration | Affects phenotype | PMID:32645486 |
| GO:0004691 | Camp-dependent protein kinase activity | Increases phenotype | PMID:33711355 |
| GO:0006007 | Glucose catabolic process | Increases phenotype | PMID:31629899 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:28392331 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:27129165 |
| GO:0006694 | Steroid biosynthetic process | Decreases phenotype | PMID:35762964 |
| GO:0006754 | Atp biosynthetic process | Increases phenotype | PMID:31629899 |
| GO:0006805 | Xenobiotic metabolic process | Increases phenotype | PMID:29162470 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:25081364 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:39921026 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:28392331 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:30802670; PMID:37788136 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:29029336; PMID:30802670; PMID:37364641; PMID:39921026 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:30802670 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:28611354; PMID:34597818 |
| GO:0008219 | Cell death | Increases phenotype | PMID:26520405; PMID:33711355 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:21241498; PMID:24213142; PMID:24213142; PMID:29864457; PMID:27129165; PMID:28855101; PMID:29864457; PMID:31016752; PMID:31319113; PMID:34428494 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:35307500 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:35739755 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:28611354; PMID:30802670 |
| GO:0009566 | Fertilization | Decreases phenotype | PMID:33711355 |
| GO:0009790 | Embryo development | Decreases phenotype | PMID:33711355 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:38995844 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:26820058 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:35739755; PMID:37364641 |
| GO:0010907 | Positive regulation of glucose metabolic process | Increases phenotype | PMID:32905190 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:36756972 |
| GO:0015278 | Calcium-release channel activity | Affects phenotype | PMID:25081364 |
| GO:0016049 | Cell growth | Increases phenotype | PMID:29864457; PMID:30243731 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:25081364; PMID:27129165 |
| GO:0018108 | Peptidyl-tyrosine phosphorylation | Increases phenotype | PMID:33711355 |
| GO:0019249 | Lactate biosynthetic process | Increases phenotype | PMID:31629899 |
| GO:0019695 | Choline metabolic process | Affects phenotype | PMID:32949613 |
| GO:0022602 | Ovulation cycle process | Affects phenotype | PMID:29969652 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:28611354; PMID:29029336; PMID:36746855 |
| GO:0030728 | Ovulation | Increases phenotype | PMID:33316053 |
| GO:0030836 | Positive regulation of actin filament depolymerization | Increases phenotype | PMID:36756972 |
| GO:0030850 | Prostate gland development | Decreases phenotype | PMID:30802670 |
| GO:0031323 | Regulation of cellular metabolic process | Affects phenotype | PMID:26820058 |
| GO:0032308 | Positive regulation of prostaglandin secretion | Increases phenotype | PMID:33316053 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:25449125; PMID:27473340 |
| GO:0034199 | Activation of protein kinase a activity | Increases phenotype | PMID:37552060 |
| GO:0034255 | Regulation of urea metabolic process | Affects phenotype | PMID:32949613 |
| GO:0034389 | Lipid droplet organization | Increases phenotype | PMID:26820058 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:39921026 |
| GO:0035148 | Tube formation | Increases phenotype | PMID:22905168 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:32518293 |
| GO:0035360 | Positive regulation of peroxisome proliferator activated receptor signaling pathway | Increases phenotype | PMID:26519955 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:28013214; PMID:30802670; PMID:31199487 |
| GO:0035938 | Estradiol secretion | Decreases phenotype | PMID:28013214 |
| GO:0035941 | Androstenedione secretion | Decreases phenotype | PMID:28013214 |
| GO:0035943 | Estrone secretion | Decreases phenotype | PMID:28013214 |
| GO:0036269 | Swimming behavior | Affects phenotype | PMID:32518293 |
| GO:0042221 | Response to chemical | Increases phenotype | PMID:34428494 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:34597818 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0042692 | Muscle cell differentiation | Increases phenotype | PMID:28298639 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:33316053 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:33511402; PMID:35739755; PMID:36756972; PMID:37364641 |
| GO:0043066 | Negative regulation of apoptotic process | Increases phenotype | PMID:31016752 |
| GO:0043970 | Histone h3-k9 acetylation | Increases phenotype | PMID:27129165 |
| GO:0044237 | Cellular metabolic process | Affects phenotype | PMID:22905168; PMID:27129165; PMID:27992464; PMID:31629899; PMID:33822518; PMID:34697989; PMID:39921026 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:22905168; PMID:31212022 |
| GO:0044849 | Estrous cycle | Affects phenotype | PMID:36929940 |
| GO:0045333 | Cellular respiration | Increases phenotype | PMID:31629899 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:24155963; PMID:27923775; PMID:34520170 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:26820058; PMID:28595985 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:35307500 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33711355 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:32518293 |
| GO:0046881 | Positive regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:37364641 |
| GO:0048240 | Sperm capacitation | Increases phenotype | PMID:33711355 |
| GO:0048246 | Macrophage chemotaxis | Increases phenotype | PMID:40323316 |
| GO:0048599 | Oocyte development | Decreases phenotype | PMID:28013214 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Increases phenotype | PMID:40323316 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:31199487 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:36746855 |
| GO:0051726 | Regulation of cell cycle | Affects phenotype | PMID:29864457 |
| GO:0055072 | Iron ion homeostasis | Affects phenotype | PMID:39921026 |
| GO:0060305 | Regulation of cell diameter | Affects phenotype | PMID:37021957 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:22905168; PMID:25081364 |
| GO:0060376 | Positive regulation of mast cell differentiation | Increases phenotype | PMID:37021957 |
| GO:0060443 | Mammary gland morphogenesis | Affects phenotype | PMID:21241498 |
| GO:0060467 | Negative regulation of fertilization | Increases phenotype | PMID:36756972 |
| GO:0060512 | Prostate gland morphogenesis | Decreases phenotype | PMID:31199487 |
| GO:0060618 | Nipple development | Affects phenotype | PMID:37788136 |
| GO:0061107 | Seminal vesicle development | Decreases phenotype | PMID:30802670 |
| GO:0061180 | Mammary gland epithelium development | Affects phenotype | PMID:21241498 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:31319113; PMID:33983380; PMID:34597818 |
| GO:0061458 | Reproductive system development | Decreases phenotype | PMID:37788136 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0070352 | Positive regulation of white fat cell proliferation | Increases phenotype | PMID:32905190 |
| GO:0071929 | Alpha-tubulin acetylation | Decreases phenotype | PMID:36756972 |
| GO:0072497 | Mesenchymal stem cell differentiation | Decreases phenotype | PMID:28298639 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:29029336; PMID:30802670; PMID:37364641 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:39921026 |
| GO:0072677 | Eosinophil migration | Increases phenotype | PMID:28392331 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:27129165 |
| GO:0090116 | C-5 methylation of cytosine | Decreases phenotype | PMID:35487445 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:32518293 |
| GO:0097202 | Activation of cysteine-type endopeptidase activity | Increases phenotype | PMID:29029336 |
| GO:0097368 | Establishment of sertoli cell barrier | Decreases phenotype | PMID:39921026 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30802670; PMID:33711355; PMID:39921026 |
| GO:0110088 | Hippocampal neuron apoptotic process | Increases phenotype | PMID:36746855 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:28595985; PMID:31016361; PMID:34864131; PMID:32407875; PMID:34520170 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:35739755 |
| GO:0160024 | Leydig cell proliferation | Affects phenotype | PMID:28611354 |
| GO:1900015 | Regulation of cytokine production involved in inflammatory response | Affects phenotype | PMID:38954831 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:40323316 |
| GO:1900194 | Negative regulation of oocyte maturation | Increases phenotype | PMID:36756972 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:35739755 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:26520405 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:36756972; PMID:38227285 |
| GO:1903786 | Regulation of glutathione biosynthetic process | Affects phenotype | PMID:32949613 |
| GO:1904177 | Regulation of adipose tissue development | Affects phenotype | PMID:37021957 |
| GO:1904598 | Positive regulation of connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:35739755 |
| GO:1905071 | Tight junction disassembly | Affects phenotype | PMID:39921026 |
| GO:1905831 | Negative regulation of spindle assembly | Affects phenotype | PMID:36756972 |
| GO:1905867 | Epididymis development | Affects phenotype | PMID:30802670 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:35739735; PMID:37788136 |
| GO:2000387 | Regulation of antral ovarian follicle growth | Decreases phenotype | PMID:36756972 |
| GO:2000437 | Regulation of monocyte extravasation | Affects phenotype | PMID:37743007 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:37839492; PMID:38227285; PMID:39947446 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:37364641 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:29029336; PMID:35163327; PMID:37839492 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:31016752; PMID:37364641 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.